Sleazy Vaccine Marketing
BB Galore
7 years ago
Featured Answer
Sort by:Oldest
Comments (20)
rob333 (zone 7b)
7 years agoVertise
7 years agolast modified: 7 years agoRelated Discussions
article link...fda approves first gmo flu vaccine
Comments (34)Common sense, Eric. Still, you can't provide proof that there is such a thing as "prevention" using vaccines. When polio ran its course, THEN modern medicine came out with "vaccines" and said "Look what we've cured!!" You can't possibly quantify nor qualify those kinds of smoke and mirrors. But modern medicine wants to take credit for "curing" a disease that had already finished running its course. Spanish influenza ran its course. Biggest cause was social stress in the aftermath of WWI and poor nutrition. Not some virus. Remember, figures lie. And liars figure. Modern medicine is chasing its tail. Besides, one last dig at modern medicine: Vaccine use is based on the germ theory of disease. But I proved with deductive reasoning a long time ago that germs don't cause any disease. (Another subject entirely.) So, again, Eric. the vaccine therapies are built on an erroneous assumption. Remember the Welhausen Theory of Higher Criticism. If a theory is built on erroneous assumptions, then the whole theory has to be thrown out. HerbDoctor...See MoreWill you take the vaccine?
Comments (38)My infant/toddler brother was one of the first people vaccinated for measles back circa 1960. He lucked out because we then lived in NYC, where much of the first batches were sent to. He also lucked out because *I* (obviously living in the same apartment) had a terribly serious case of measles, that lasted a couple weeks or so). I am glad it worked out for him. I wish the vaccine had been around sooner. At any rate, I'm not going to be first in line for this coronavirus vaccine. I'm going to remain careful until actual data are in, and I think with my immunological training, if I have access to some source data and journals, I'll decide for myself if ready for the vaccine. I also hope other types of treatments are properly vetted - various drugs and what-not - that will cure or mitigate the disease. I don't necessarily expect cures from that source, but it is very likely that the disease can be mitigated following proper research. PS. I don't take the flu shot every year - but I did for about six years after having the flu so severely I went to a walk in clinic and they supplied me with a high oxygen humid air treatment for an hour or so. Before I'd gone there, the only time I didn't cough was when I was in the shower, steam coursing all through me. AS SOON AS I stepped out, I was coughing again....See MorePromising vaccine news
Comments (4)This article is a really interesting view into how vaccine trials work. It makes sense that each phase would be aimed at verifying important factors: safety and efficacy. Sounds like the phase 1 that has been completed shows promising immune response and safety (within a small group) but does not yet demonstrate efficacy. Reading about some recent cases where patients had tested positive for COVID-19, then recovered and tested negative, and then re-infected and tested positive again suggests that our bodies may not naturally develop immunity to the infection. This is also seen in other coronaviruses like the common cold. I am by no means an expert on the topic, but it sounds like this could make effective vaccine development challenging. I really really hope that with such brilliant scientists working on vaccines that a safe effective vaccine will be developed!...See MorePhase three vaccine testing - COVID
Comments (26)There are 3 vaccine candidates in Phase 3 trials in the US: September 01, 2020 Today the United States has three COVID-19 vaccine candidates in phase 3 trials, as AstraZeneca launched the final stage of a trial of its vaccine candidate, which it plans to test in 30,000 healthy adults. The AstraZeneca vaccine, developed at Oxford University, is already in a phase 3 trial in the United Kingdom. The first US volunteers were inoculated today at the University of Wisconsin School of Medicine and Public Health in Madison, and AstraZeneca plans to add 50 participants each day after Sep 7. In addition to the AstraZeneca vaccine, Moderna’s vaccine candidate is already in phase 3 trials in the United States, as is Pfizer and BioNTech's. https://www.cidrap.umn.edu/news-perspective/2020/09/third-covid-vaccine-candidate-starts-phase-3-trial-us July 28, 2020 Pfizer and German biotech partner BioNTech have on the same day as rival Moderna kick-started a late-stage effort for their “best” attempt at an mRNA pandemic vaccine. Moderna announced early Monday that, alongside a near half-billion extra in Biomedical Advanced Research and Development Authority dollars, it has started a boosted 30,000-patient phase 3 for its vaccine; not to be left out, Pfizer and BioNTech announced after-hours that they too were starting a late-stage attempt. Unlike Moderna, however, the partners have four shots on target; we’ve already seen early data out from one, which showed an immune response and a manageable safety profile, but now the partners are putting forward a new shot on goal, which they think is better. https://www.fiercebiotech.com/biotech/pfizer-biontech-start-their-covid-vax-phase-3-squaring-off-moderna More than 150 coronavirus vaccines are in development across the world—and hopes are high to bring one to market in record time to ease the global crisis. Dozens of COVID-19 Vaccines are in Development...See MoreAdella Bedella
7 years agosleeperblues
7 years agosjerin
7 years agoElmer J Fudd
7 years agoJasdip
7 years agorob333 (zone 7b)
7 years agolast modified: 7 years agosjerin
7 years agosleeperblues
7 years agorob333 (zone 7b)
7 years agobob_cville
7 years agolisa_fla
7 years agosleeperblues
7 years agoarcy_gw
7 years agorob333 (zone 7b)
7 years agolast modified: 7 years agoElmer J Fudd
7 years agolast modified: 7 years agoTexas_Gem
7 years agoRenee Texas
7 years agolast modified: 7 years ago
Related Stories
SELLING YOUR HOUSE15 Questions to Ask When Interviewing a Real Estate Agent
Here’s what you should find out before selecting an agent to sell your home
Full StoryLIFETo-Dos: Your October Home Checklist
It’s a great time to clean your gutters, swap out seasonal clothes and wallow in favorite fall traditions. What’s on your October list?
Full StoryHOME TECHWhy Google Just Paid $3.2 Billion for a Company That Makes Thermostats
Smart home technology just got a new champion — and everyone is speculating about the reasons
Full StoryWORKING WITH PROS10 Things Decorators Want You to Know About What They Do
They do more than pick pretty colors. Here's what decorators can do for you — and how you can help them
Full StoryCOMMUNITYIn L.A.’s Echo Park, a New Urban Development Takes Flight
Blackbirds, a new ‘microneighborhood’ near downtown, is Los Angeles’ latest small-lot urban infill project
Full StoryDECORATING GUIDESBring in da Funk: How Humble Touches Give a Home Soul
Shake up expectations and stir up interest with pieces that show patina, create contrast or offer a jolt of surprise
Full StoryMOVINGHow to Make Your Move Easier for Your Family
Say goodbye to a much-loved home and settle in quickly to a new place with these tips for transitioning
Full StoryORGANIZINGOrganizing Secrets: It’s the Little Things
Get these 8 small areas under control for a major boost in overall tidiness at home
Full StoryLIFEHow to Outsmart Backyard Critters
Learn to think like a raccoon, skunk or squirrel to keep your home safe and your garden intact
Full StoryLIFERelocating? Here’s How to Make Moving In a Breeze
Moving guide, Part 2: Helpful tips for unpacking, organizing and setting up your new home
Full Story
Elmer J Fudd